Who owns NRX Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NRXP from SEC Form 13F filings across 47 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 47 institutions disclosed 11.6M shares of NRX Pharmaceuticals, Inc. worth $47.1M — about 30.9% of shares outstanding; the largest disclosed holder is B Group, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
47
13F holders
$47.1M
value, 2026 filers
30.9%
of shares outstanding (11.6M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NRXP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | B Group, Inc. | 4.1M | $16.7M | 7.9% | 10.9% | +36.4% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $6.6M | 0.0% | 4.3% | +39.5% |
| 3 | AMERIPRISE FINANCIAL INCNEW | 928,728 | $3.8M | 0.0% | 2.5% | new |
| 4 | Balyasny Asset Management L.P.NEW | 893,864 | $3.7M | 0.0% | 2.4% | new |
| 5 | CITADEL ADVISORS LLCNEW | 680,043 | $2.8M | 0.0% | 1.8% | new |
| 6 | AdvisorShares Investments LLC | 659,018 | $2.7M | 0.3% | 1.8% | +56.7% |
| 7 | COMMONWEALTH EQUITY SERVICES, LLC | 454,418 | $1.9M | 0.0% | 1.2% | +14.3% |
| 8 | UBS Group AG | 423,115 | $1.7M | 0.0% | 1.1% | +1577.2% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 314,659 | $1.3M | 0.0% | 0.8% | +1.5% |
| 10 | BlackRock, Inc. | 220,460 | $901,681 | 0.0% | 0.6% | +122.7% |
| 11 | MARSHALL WACE, LLPNEW | 194,580 | $795,831 | 0.0% | 0.5% | new |
| 12 | VANGUARD FIDUCIARY TRUST CO | 182,718 | $747,317 | 0.0% | 0.5% | +7.7% |
| 13 | JANE STREET GROUP, LLC | 119,018 | $486,784 | 0.0% | 0.3% | +169.6% |
| 14 | Bleakley Financial Group, LLC | 117,216 | $479,413 | 0.0% | 0.3% | 0.0% |
| 15 | STATE STREET CORP | 116,084 | $474,784 | 0.0% | 0.3% | +33.5% |
| 16 | HRT FINANCIAL LPNEW | 100,724 | $411 | 0.0% | 0.3% | new |
| 17 | NORTHERN TRUST CORP | 62,951 | $257,470 | 0.0% | 0.2% | +44.8% |
| 18 | Chicago Partners Investment Group LLC | 46,388 | $190,655 | 0.0% | 0.1% | +34.5% |
| 19 | Quadrature Capital LtdNEW | 43,605 | $178,344 | 0.0% | 0.1% | new |
| 20 | One Wealth Management Investment & Advisory Services, LLCNEW | 43,309 | $177,134 | 0.2% | 0.1% | new |
| 21 | MORGAN STANLEY | 40,901 | $167,285 | 0.0% | 0.1% | +307.9% |
| 22 | RENAISSANCE TECHNOLOGIES LLCNEW | 38,600 | $157,874 | 0.0% | 0.1% | new |
| 23 | Global Retirement Partners, LLCNEW | 33,300 | $136,197 | 0.0% | 0.1% | new |
| 24 | TWO SIGMA INVESTMENTS, LPNEW | 26,429 | $108,095 | 0.0% | 0.1% | new |
| 25 | TRUIST FINANCIAL CORPNEW | 20,000 | $81,800 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.